What is a required record when a prescription drug is sold by a manufacturer to a chain pharmacy's warehouse?

When a prescription drug is sold by a manufacturer to a chain pharmacy's warehouse, it is essential to maintain detailed records that include the product and lot information. This requirement is rooted in regulatory standards that mandate comprehensive tracking of pharmaceuticals to ensure safety, accountability, and quality control throughout the supply chain.

The product and lot information provides critical data that can be used for various purposes, including tracing the distribution of specific batches of drugs in the event of a recall or adverse events. This information helps in identifying affected products quickly and efficiently, thus protecting public health.

In addition, product and lot information is vital for compliance with regulatory requirements imposed by entities such as the FDA and other health authorities. This traceability is a core component of Good Manufacturing Practices (GMP) and ensures that records are kept meticulously to reflect the status of each batch and its compliance with safety standards.

Other options, while they may pertain to aspects of drug management or business operations, do not meet the regulatory requirements for record-keeping in this context. Therefore, maintaining accurate product and lot information is the correct choice when documenting the sale of prescription drugs from manufacturers to pharmacies.